Skip to content

Comparing Different Homoeopathic Treatments used for Lichen Planus by using Different Homoeopathic books

Comparative Study Of Different Prescription Based On Different Materia Medica In Lichen Planus - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090917
Enrollment
30
Registered
2025-07-15
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L439- Lichen planus, unspecified

Interventions

Intervention1: Individualized Homoeopathic Medicine: Individualized Homoeopathic Medicines Will Be Prescribed On The basis Of Totality Of Symptoms And Individual Susceptibility The Medicine Will Be Ad

Sponsors

C D Pachchigar College Of Homoeopathic Medicine And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Includes Cases Of All Age Group And Both Sexes 2 Cases Which Are Newly Diagnosed By me 3 Cases Which Are Already Diagnosed With or Without Any Conventional Treatment Taken

Exclusion criteria

Exclusion criteria: 1 Cases Which Having Advanced Skin Pathology Like Psoriasis , Skin Cancer ,Pemphigus vulgaris etc.. 2 Patient Who Dropped Follow Up

Design outcomes

Primary

MeasureTime frame
To Compare the Prescription Based on J T Kent Homoeopathic Materia Medica ,Allens Keynote Metria Medica And On Lilenthal Therapeutics With Assesment The Changes And Extent Of Lichen Planus Lesions Like Itching,Pain,Quality Of Life And Determine The Frequency Of Repetition And Potency ResponseTimepoint: 9 Months

Secondary

MeasureTime frame
To Understand Different Approach Of Prescription In HomoeopathyTimepoint: 9 Months

Countries

India

Contacts

Public ContactDr Gaurang Dave

C D Pachchigar College Of Homoeopathic Medicine And Hospital

drgaurangdave@gmail.com8141699333

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026